Skip to main content
Erschienen in: Annals of Hematology 5/2009

01.05.2009 | Original Article

Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy

verfasst von: Dietmar Jörg Dinter, Wolfgang K. Neff, Johanna Klaus, Christoph Böhm, Jan Hastka, Christel Weiss, Stefan O. Schoenberg, Georgia Metzgeroth

Erschienen in: Annals of Hematology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Skeletal X-ray survey is the established method of diagnosis in patients with multiple myeloma; however, whole-body magnetic resonance imaging (wb-MRI) has become an important additional tool. The aim of this study was to compare the different patterns of infiltration on conventional X-ray examinations (X-ray survey) with findings from wb-MRI to subsequently determine the influence of wb-MRI on therapy changes. In 60 patients with a mean age of 65.1 ± 11.7 years, wb-MRI examinations were correlated with a recent X-ray survey. The results were independently assessed by two radiologists and the patterns of infiltration were described in both modalities. Subsequently, the disease was staged according to Salmon and Durie and Salmon and Durie PLUS. Additionally, the influence of MRI on potential changes in therapy was assessed using a three-range Likert-type scale. In all, 480 skeletal regions were compared. In 183 skeletal regions, an increased degree of infiltration was identified on wb-MRI. Significant differences (p < 0.05) between the modalities could be found in the thorax, spine, pelvis, and both lower extremities. Based on wb-MRI, tumor stage was upgraded in 19 of the 60 patients using the Durie and Salmon PLUS classification. In ten out of these 19 patients (42%), the wb-MRI result was essential for making the decision to initiate further therapy due to the degree of infiltration, extramedullary tumor extension, and/or further risk of fracture. Whole-body MRI provides a more detailed assessment of the pattern of bone marrow infiltration and strongly influences therapeutic strategies.
Literatur
1.
Zurück zum Zitat Kelly JJ (1999) Neuropathies of monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North 13(6):1203–1210CrossRef Kelly JJ (1999) Neuropathies of monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North 13(6):1203–1210CrossRef
2.
Zurück zum Zitat Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M (2002) Magnetic resonance imaging as a supplement for the clinical staging system of Durie und Salmon? Cancer 95(6):1334–1345PubMedCrossRef Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M (2002) Magnetic resonance imaging as a supplement for the clinical staging system of Durie und Salmon? Cancer 95(6):1334–1345PubMedCrossRef
3.
Zurück zum Zitat Durie BG (2006) The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42(11):1539–1543PubMedCrossRef Durie BG (2006) The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42(11):1539–1543PubMedCrossRef
4.
Zurück zum Zitat Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gahrton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Oken M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B, Scientific Advisors of the International Myeloma Foundation (2003) Myeloma management guidelines, a consensus report from the Scientific Advisors of International Myeloma Foundation. Hematol J 4(6):379–398PubMedCrossRef Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gahrton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Oken M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B, Scientific Advisors of the International Myeloma Foundation (2003) Myeloma management guidelines, a consensus report from the Scientific Advisors of International Myeloma Foundation. Hematol J 4(6):379–398PubMedCrossRef
5.
Zurück zum Zitat Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854PubMedCrossRef Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854PubMedCrossRef
6.
Zurück zum Zitat Baur A, Stäbler A, Bartl R, Lamerz R, Reiser M (1996) Infiltration patterns of plasmacytomas in magnetic resonance tomography. RoFo 164(6):457–463PubMed Baur A, Stäbler A, Bartl R, Lamerz R, Reiser M (1996) Infiltration patterns of plasmacytomas in magnetic resonance tomography. RoFo 164(6):457–463PubMed
7.
Zurück zum Zitat Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55(1):56–63PubMedCrossRef Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55(1):56–63PubMedCrossRef
8.
Zurück zum Zitat Eustace S, Tello R, Decarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole body turbo STIR MR imaging and planar 99Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655–1661PubMed Eustace S, Tello R, Decarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole body turbo STIR MR imaging and planar 99Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655–1661PubMed
9.
Zurück zum Zitat Lecouvet FE, Vande Berg BC, Michaux L, Malghem J, Maldague BE, Jamart J, Ferrant A, Michaux JL (1998) Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 209(3):653–660PubMed Lecouvet FE, Vande Berg BC, Michaux L, Malghem J, Maldague BE, Jamart J, Ferrant A, Michaux JL (1998) Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 209(3):653–660PubMed
10.
Zurück zum Zitat Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, Jamart J, Ferrant A, Vande Berg BC (1997) Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 204(1):201–205PubMed Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, Jamart J, Ferrant A, Vande Berg BC (1997) Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 204(1):201–205PubMed
11.
Zurück zum Zitat Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, Brouet JC, Fermand JP (1999) Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 104:723–729PubMedCrossRef Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, Brouet JC, Fermand JP (1999) Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 104:723–729PubMedCrossRef
12.
Zurück zum Zitat Steinborn M, Tilling R, Heuck A, Brügel M, Gauger L, Reiser M (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129PubMedCrossRef Steinborn M, Tilling R, Heuck A, Brügel M, Gauger L, Reiser M (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129PubMedCrossRef
13.
Zurück zum Zitat Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M (2004) Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histologic findings. Cancer 101:2599–2604PubMedCrossRef Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M (2004) Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histologic findings. Cancer 101:2599–2604PubMedCrossRef
14.
Zurück zum Zitat Lecouvet FE, Malghem JL, Michaux L, Maldague B, Ferrant A, Michaux JL, Vande Berg BC (1999) Skeletal survey in advanced multiple myeloma: radiography versus MRI survey. Br J Haematol 106(1):35–39PubMedCrossRef Lecouvet FE, Malghem JL, Michaux L, Maldague B, Ferrant A, Michaux JL, Vande Berg BC (1999) Skeletal survey in advanced multiple myeloma: radiography versus MRI survey. Br J Haematol 106(1):35–39PubMedCrossRef
15.
Zurück zum Zitat Ghanem N, Altehöffer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumor of axial skeleton. Eur J Radiol 43(3):256–261PubMedCrossRef Ghanem N, Altehöffer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumor of axial skeleton. Eur J Radiol 43(3):256–261PubMedCrossRef
16.
Zurück zum Zitat Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55(1):41–55PubMedCrossRef Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55(1):41–55PubMedCrossRef
17.
Zurück zum Zitat Schäfer FJ, Fischmann A, Lichy M, Vollmar J, Fenchel M, Claussen CD, Schlemmer HP (2004) Oncologic screening with whole-body MRI: possibilities and limitations. Radiologe 44:854–863PubMedCrossRef Schäfer FJ, Fischmann A, Lichy M, Vollmar J, Fenchel M, Claussen CD, Schlemmer HP (2004) Oncologic screening with whole-body MRI: possibilities and limitations. Radiologe 44:854–863PubMedCrossRef
18.
Zurück zum Zitat Ghanem N, Lohrmann C, Engelhard M, Pache G, Uhl M, Saueressig U, Kotter E, Langer M (2006) Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to radiologic skeletal survey. Eur Radiol 16(5):1005–1014PubMedCrossRef Ghanem N, Lohrmann C, Engelhard M, Pache G, Uhl M, Saueressig U, Kotter E, Langer M (2006) Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to radiologic skeletal survey. Eur Radiol 16(5):1005–1014PubMedCrossRef
19.
20.
Zurück zum Zitat Ludwig H, Frühwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E (1987) Magnetic resonance imaging of the spine in multiple myeloma. Lancet 2(8555):364–366PubMedCrossRef Ludwig H, Frühwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E (1987) Magnetic resonance imaging of the spine in multiple myeloma. Lancet 2(8555):364–366PubMedCrossRef
21.
Zurück zum Zitat Frühwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23(3):193–199CrossRef Frühwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23(3):193–199CrossRef
22.
Zurück zum Zitat Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F (2001) Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 28(6):543–550PubMedCrossRef Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F (2001) Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 28(6):543–550PubMedCrossRef
23.
Zurück zum Zitat Vande Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1996) Stage I multiple myeloma: value of MRI in the bone marrow in the determination of prognosis. Radiology 201(1):243–246 Vande Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1996) Stage I multiple myeloma: value of MRI in the bone marrow in the determination of prognosis. Radiology 201(1):243–246
24.
Zurück zum Zitat Vande Berg BC, Michaux L, Lecouvet FE, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202(1):247–251PubMed Vande Berg BC, Michaux L, Lecouvet FE, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202(1):247–251PubMed
25.
Zurück zum Zitat Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R (1995) Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 13(1):251–256PubMed Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R (1995) Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 13(1):251–256PubMed
26.
Zurück zum Zitat Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ (2007) Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 25(9):1121–1128PubMedCrossRef Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ (2007) Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 25(9):1121–1128PubMedCrossRef
27.
Zurück zum Zitat Antoch G, Vogt FM, Bockisch A, Rühm SG (2004) Whole-body tumor staging: MRI or FDG–PET/CT? Radiologe 44(9):882–888PubMedCrossRef Antoch G, Vogt FM, Bockisch A, Rühm SG (2004) Whole-body tumor staging: MRI or FDG–PET/CT? Radiologe 44(9):882–888PubMedCrossRef
28.
Zurück zum Zitat Baur A, Stäbler A, Steinborn M, Schnarkowski P, Pistitsch C, Lamerz R, Bartl R, Reiser M (1998) Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns. RoFo 168(4):323–329PubMed Baur A, Stäbler A, Steinborn M, Schnarkowski P, Pistitsch C, Lamerz R, Bartl R, Reiser M (1998) Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns. RoFo 168(4):323–329PubMed
29.
Zurück zum Zitat Moulopoulos LA, Dimopoulos MA (1997) Magnetic resonance imaging of bone marrow in haematologic malignancies. Blood 90(6):2127–2147PubMed Moulopoulos LA, Dimopoulos MA (1997) Magnetic resonance imaging of bone marrow in haematologic malignancies. Blood 90(6):2127–2147PubMed
30.
Zurück zum Zitat Baur-Melnyk A, Reiser M (2004) Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography. Radiologe 44(9):874–881PubMedCrossRef Baur-Melnyk A, Reiser M (2004) Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography. Radiologe 44(9):874–881PubMedCrossRef
31.
Zurück zum Zitat Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N, Anglade MC, Reyes F, VasiIe N (1993) Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR-imaging. AJR Am J Roentgenol 160(5):1049–1052PubMed Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N, Anglade MC, Reyes F, VasiIe N (1993) Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR-imaging. AJR Am J Roentgenol 160(5):1049–1052PubMed
32.
Zurück zum Zitat Wasser K, Möhler T, Nosas-Garcia S, Rehm C, Bartl R, Goldschmidt JH, Düber C, Kauczor HU, Delorme S (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. RoFo 177(8):1116–1122PubMed Wasser K, Möhler T, Nosas-Garcia S, Rehm C, Bartl R, Goldschmidt JH, Düber C, Kauczor HU, Delorme S (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. RoFo 177(8):1116–1122PubMed
33.
Zurück zum Zitat Buss DH, Prichard RW, Hartz JW, Cooper MR, Feigin GA (1986) Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Arch Pathol Lab Med 110(1):30–33PubMed Buss DH, Prichard RW, Hartz JW, Cooper MR, Feigin GA (1986) Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Arch Pathol Lab Med 110(1):30–33PubMed
34.
Zurück zum Zitat Schmidt GP, Baur A, Stäbler A, Schönberg SO, Steinborn M, Baltin V, Reiser MF (2005) Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results. RoFo 177(5):745–750PubMed Schmidt GP, Baur A, Stäbler A, Schönberg SO, Steinborn M, Baltin V, Reiser MF (2005) Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results. RoFo 177(5):745–750PubMed
35.
Zurück zum Zitat Rahmouni A, Divine M, Mathieu D, Golli M, Hajoun C, Dao T, Anglade MC, Reyes F, Vasile N (1993) MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 160(5):1053–1057PubMed Rahmouni A, Divine M, Mathieu D, Golli M, Hajoun C, Dao T, Anglade MC, Reyes F, Vasile N (1993) MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 160(5):1053–1057PubMed
Metadaten
Titel
Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy
verfasst von
Dietmar Jörg Dinter
Wolfgang K. Neff
Johanna Klaus
Christoph Böhm
Jan Hastka
Christel Weiss
Stefan O. Schoenberg
Georgia Metzgeroth
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 5/2009
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-008-0621-6

Weitere Artikel der Ausgabe 5/2009

Annals of Hematology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.